Pro-Dex (NASDAQ:PDEX) Share Price Crosses Above 200 Day Moving Average – Should You Sell?

Pro-Dex, Inc. (NASDAQ:PDEX)’s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $38.44 and traded as high as $39.38. Pro-Dex shares last traded at $38.45, with a volume of 21,858 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Pro-Dex in a research note on Monday, December 29th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $56.00.

Pro-Dex Stock Down 2.2%

The company has a market cap of $123.42 million, a P/E ratio of 11.31 and a beta of -0.05. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.25 and a current ratio of 4.03. The business’s fifty day moving average is $40.55 and its two-hundred day moving average is $38.44.

Pro-Dex (NASDAQ:PDEX) last issued its earnings results on Thursday, January 29th. The medical instruments supplier reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.07. Pro-Dex had a net margin of 15.73% and a return on equity of 22.53%. The business had revenue of $18.66 million for the quarter, compared to analyst estimates of $17.30 million. Equities analysts predict that Pro-Dex, Inc. will post 2 EPS for the current year.

Institutional Investors Weigh In On Pro-Dex

Hedge funds have recently made changes to their positions in the company. D.A. Davidson & CO. grew its position in shares of Pro-Dex by 152.3% during the 3rd quarter. D.A. Davidson & CO. now owns 26,073 shares of the medical instruments supplier’s stock worth $883,000 after buying an additional 15,738 shares in the last quarter. CreativeOne Wealth LLC purchased a new stake in Pro-Dex in the second quarter worth about $297,000. Hillsdale Investment Management Inc. bought a new position in Pro-Dex during the 2nd quarter worth about $157,000. Ritholtz Wealth Management increased its position in Pro-Dex by 32.4% during the 2nd quarter. Ritholtz Wealth Management now owns 21,102 shares of the medical instruments supplier’s stock valued at $921,000 after purchasing an additional 5,158 shares during the period. Finally, Morgan Dempsey Capital Management LLC purchased a new position in Pro-Dex during the 2nd quarter valued at about $179,000. 15.28% of the stock is currently owned by hedge funds and other institutional investors.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.